Amedeo's Top 20

Amedeo Smart

Independent Medical Education

15 December 2014

Multidisciplinary Journal Club

  1. .
    Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial.
    Lancet 2014.

  1. Boileau JF, Poirier B, Basik M, Holloway CM, et al.
    Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: The SN FNAC Study.
    J Clin Oncol 2014.

  2. Thevenot T, Bureau C, Oberti F, Anty R, et al.
    Effect of Albumin in Cirrhotic Patients with Infection Other Than Spontaneous Bacterial Peritonitis. A Randomized Trial.
    J Hepatol 2014.

  3. Westbrook RH, Dusheiko G.
    Natural history of hepatitis C.
    J Hepatol 2014;61:S58-S68.

  4. Boulain T, Boisrame-Helms J, Ehrmann S, Lascarrou JB, et al.
    Volume expansion in the first 4 days of shock: a prospective multicentre study in 19 French intensive care units.
    Intensive Care Med 2014.

  1. Janz DR, Bastarache JA, Rice TW, Bernard GR, et al.
    Randomized, Placebo-Controlled Trial of Acetaminophen for the Reduction of Oxidative Injury in Severe Sepsis: The Acetaminophen for the Reduction of Oxidative injury in Severe Sepsis Trial.
    Crit Care Med 2014.

  2. Doeser A, Dickhof G, Reitze M, Uebachs M, et al.
    Targeting pharmacoresistant epilepsy and epileptogenesis with a dual-purpose antiepileptic drug.
    Brain 2014.

  3. Devanand DP, Lee S, Manly J, Andrews H, et al.
    Olfactory deficits predict cognitive decline and Alzheimer dementia in an urban community.
    Neurology 2014.

  4. Sarkar M, Watt KD, Terrault N, Berenguer M, et al.
    Outcomes in Liver Transplantation: Does Sex Matter?
    J Hepatol 2014.

  5. Steed AL, Stappenbeck TS.
    Role of viruses and bacteria-virus interactions in autoimmunity.
    Curr Opin Immunol 2014;31C:102-107.

  1. Liu X, Qiang W, Liu X, Liu L, et al.
    A second course of antithyroid drug therapy for recurrent Graves' disease: An experience in endocrine practice.
    Eur J Endocrinol 2014.

  2. Braunwald E.
    The war against heart failure: the Lancet lecture.
    Lancet 2014.

  3. Olaru ID, von Groote-Bidlingmaier F, Heyckendorf J, Yew WW, et al.
    Novel drugs against tuberculosis: a clinician's perspective.
    Eur Respir J 2014.

  4. Bone HG, Dempster DW, Eisman JA, Greenspan SL, et al.
    Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial.
    Osteoporos Int 2014.

  5. Pathak RK, Middeldorp ME, Lau DH, Mehta AB, et al.
    Aggressive Risk Factor Reduction Study for Atrial Fibrillation and Implications for the Outcome of Ablation: The ARREST-AF Cohort Study.
    J Am Coll Cardiol 2014;64:2222-31.

  1. Faron M, Pignon JP, Malka D, Bourredjem A, et al.
    Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trials.
    Eur J Cancer 2014.

  2. Ortqvist AK, Lundholm C, Kieler H, Ludvigsson JF, et al.
    Antibiotics in fetal and early life and subsequent childhood asthma: nationwide population based study with sibling analysis.
    BMJ 2014;349:g6979.

  3. Caroli A, Prestia A, Wade S, Chen K, et al.
    Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI.
    Alzheimer Dis Assoc Disord 2014.

  4. Kieseier BC, Arnold DL, Balcer LJ, Boyko AA, et al.
    Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE.
    Mult Scler 2014.

  5. Ristagno G, Mauri T, Cesana G, Li Y, et al.
    Amplitude Spectrum Area to Guide Defibrillation: A Validation on 1617 Ventricular Fibrillation Patients.
    Circulation 2014.


Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016